An observational study in Nosocomial Rotavirus Gastroenteritis and Rotavirus Gastroenteritis, sponsored by GlaxoSmithKline. Completed. Open to participants aged Up to 6 Years. Per ClinicalTrials.gov, last updated 2017-06-07.
Sponsored by GlaxoSmithKline · Observational
The purpose of this study is to evaluate the epidemiology and baseline disease burden of rotavirus gastroenteritis in children \< 6 years of age, in Japan.
This is a retrospective database study wherein data on children who have been diagnosed with acute gastroenteritis or rotavirus gastroenteritis will be collected from the electronic admission database or any other applicable database of the participating hospitals.
243 studies on the registry are indexed under Gastroenteritis; 15 are open to participants now.
This study's enrollment of 13,767 is above the median of 611 across 71 observational studies indexed under Gastroenteritis.
Browse Gastroenteritis studies →GlaxoSmithKline is the lead sponsor of 3,561 studies on the registry; 116 are open to participants now.
Of its 258 completed or terminated interventional studies of FDA-regulated products, 232 (90%) have results posted.
Counted across the registry records on this site, refreshed daily.
Children \<6 years of age hospitalized with acute gastroenteritis or rotavirus gastroenteritis in any of the participating hospitals
Exclusion Criteria:
Subjects hospitalized with acute gastroenteritis or rotavirus gastroenteritis
Other: Database analysis
Review and collect data from database (electronic admission database or any other applicable database of the hospital)
Occurrence of acute gastroenteritis among all hospitalized children aged <6 years
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Occurrence of rotavirus gastroenteritis among all hospitalized children aged <6 years
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Occurrence of rotavirus gastroenteritis among all acute gastroenteritis hospitalizations in children aged <6 years
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Occurrence of nosocomial rotavirus gastroenteritis among all hospitalized children aged <6 years
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Occurrence of nosocomial rotavirus gastroenteritis among all hospitalizations with rotavirus gastroenteritis in children aged <6 years
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Prolongation of hospitalization of patients with nosocomial rotavirus gastroenteritis
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Occurrence of rotavirus gastroenteritis hospitalization and nosocomial rotavirus gastroenteritis hospitalization among children <6 years of age, stratified by age
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Seasonal distribution (monthly) of rotavirus gastroenteritis infection
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Age (monthly) specific data of all the outcome measures, for children <12 months of age
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
Number of hospitalizations with rotavirus gastroenteritis and other vaccine-preventable infectious diseases such as influenza, mumps and varicella among children <6 years of age
Time frame: At least 24 months (from 01 January 2008 to 31 December 2009)
No study locations are listed for this record.
This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GlaxoSmithKline